Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jan 15 2025

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jan-15-2025-5

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 15, 2025, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases